Daily non-political popular news in brief.

Reducing cardiovascular disease risk factors when discontinuing hormone replacement therapy

Hormone replacement therapy (HRT) can reduce many cardiovascular disease (CVD) risks, but many women have stopped using HRT due to reports that HRT may increase the risk of breast cancer and heart disease. In a study published in the June issue of the American Journal of Preventive Medicine, researchers from the University of Pittsburgh Graduate School of Public Health examined whether the increased CVD risk from stopping HRT could be minimized by lifestyle change intervention.

Read more »

Keywords: reducing, cardiovascular, disease, risk, factors, discontinuing, hormone, replacement, therapy, factor

« Previous | Next »

Similar news on "Reducing cardiovascular disease risk factors when discontinuing hormone replacement therapy":

1. Advance in understanding of blood pressure gene could lead to new treatments
   02-04-2007 · EurekAlert!
   Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
   Similar news · Read more »
   
2. Cardiovascular disease death rates decline, but risk factors still exact heavy toll
   12-20-2007 · EurekAlert!
   Cardiovascular disease death rates are declining, but CVD is still the No. 1 cause of death in the United States, and risk factor control remains a challenge for many, according to the most recent data from the American Heart Association's Heart Disease and Stroke Statistics-2008 Update. The update will be available in the Dec. 17 online issue of Circulation: Journal of the American Heart Association.
   Similar news · Read more »
   
3. CRP liver protein induces hypertension,UT Southwestern researchers have found
   02-19-2007 · UT Southwestern Medical Center
   C-Reactive Protein, widely regarded as a risk factor for hypertension and other forms of cardiovascular disease, plays a direct role in the onset of hypertension, researchers at UT Southwestern Medical Center have found.
   Similar news · Read more »
   
4. Eating competence may lower risk of heart disease
   09-18-2007 · EurekAlert!
   People who are confident, comfortable and flexible with their eating habits may be at a significantly lower risk of cardiovascular disease than people who are not. Researchers at Penn State suggest that a curriculum that helps people understand their eating habits could prove to be an important medical nutrition therapy.
   Similar news · Read more »
   
5. Timing of start of hormone therapy may have effect on risk of coronary heart disease
   04-03-2007 · EurekAlert!
   Women who initiate hormone therapy closer to menopause tend to have a reduced risk of coronary heart disease compared to women who begin treatment further from menopause, but researchers did not find this reduced risk was statistically significant, according to a study in the April 4 issue of JAMA.
   Similar news · Read more »
   
6. Studies explore lifestyle choices and heart risks
   03-24-2007 · EurekAlert!
   Genetics and family history play a large role in a person’s risk for heart disease, but factors in diet, lifestyle and the environment are also thought to influence susceptibility to the disease. A number of studies presented today at the American College of Cardiology’s 56th Annual Scientific Session look at how health-related behaviors can influence a person’s risk for cardiovascular disease.
   Similar news · Read more »
   
7. Light activity can help avoid chronic disease
   06-11-2007 · EurekAlert!
   Reducing time spent sitting and increasing light physical activity has important health benefits that may reduce the risk of diabetes and other cardiovascular diseases.
   Similar news · Read more »
   
8. Children who learn heart healthy eating habits lower heart disease risk
   09-11-2007 · EurekAlert!
   A new study in Circulation confirms that when young children learn about heart healthy eating habits, it can strongly influence their heart disease risk later in life. A child's fat intake, primarily reduction in intake of foods rich in saturated fat, was found to be one of the greatest influencing factors in reducing cholesterol levels.
   Similar news · Read more »
   
9. Higher death rates in kidney patients with newly recognized disease
   09-28-2007 · EurekAlert!
   A new study on the prevalence of NSF and its risk factors found that the disease is associated with an increased risk of dying and that gadolinium exposure is a significant risk factor for developing it.
   Similar news · Read more »
   
10. Researchers find that screening children for heart disease risk helps to identify parents at risk
    12-05-2006 · EurekAlert!
    Screening children for risk factors associated with cardiovascular disease can help identify parents at risk for the condition, providing an opportunity for medical intervention in both children and their parents, according to research at Children's Hospital of Pittsburgh of UPMC.
    Similar news · Read more »